Black Diamond Therapeutics, Inc. (BDTX)
1.805
-0.14
(-6.96%)
USD |
NASDAQ |
Oct 06, 16:00
1.805
0.00 (0.00%)
After-Hours: 20:00
Black Diamond Therapeutics Net Income (Quarterly) : -9.905M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -9.905M |
| March 31, 2026 | -9.036M |
| December 31, 2025 | -15.12M |
| September 30, 2025 | -8.498M |
| June 30, 2025 | -10.56M |
| March 31, 2025 | 56.54M |
| December 31, 2024 | -15.98M |
| September 30, 2024 | -15.56M |
| June 30, 2024 | -19.91M |
| March 31, 2024 | -18.22M |
| December 31, 2023 | -19.41M |
| September 30, 2023 | -23.01M |
| June 30, 2023 | -19.15M |
| March 31, 2023 | -20.88M |
| December 31, 2022 | -21.08M |
| September 30, 2022 | -21.65M |
| Date | Value |
|---|---|
| June 30, 2022 | -22.93M |
| March 31, 2022 | -25.51M |
| December 31, 2021 | -25.87M |
| September 30, 2021 | -35.08M |
| June 30, 2021 | -34.35M |
| March 31, 2021 | -30.30M |
| December 31, 2020 | -22.63M |
| September 30, 2020 | -17.91M |
| June 30, 2020 | -14.57M |
| March 31, 2020 | -12.14M |
| December 31, 2019 | -9.875M |
| September 30, 2019 | -9.266M |
| June 30, 2019 | -12.29M |
| March 31, 2019 | -3.828M |
| December 31, 2018 | -3.066M |
| September 30, 2018 | -2.36M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Agenus, Inc. | -0.567M |
| Amgen, Inc. | 2.375B |
| BioCryst Pharmaceuticals, Inc. | 78.40M |
| Imunon, Inc. | -2.814M |
| Curis, Inc. | -8.581M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 9.905M |
| EPS Diluted (Quarterly) | -0.1727 |
| Enterprise Value | 17.91M |
| Earnings Yield | -41.26% |
| Normalized Earnings Yield | -36.26 |